Bruce J. Auerbach

1.8k citations

40 papers · 1.4k indexed · h-index 21

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
Surgery top 5%
- Lipoproteins and Cardiovascular Health 20
- Cholesterol and Lipid Metabolism 8
Biochemistry top 10%
Cancer Research top 10%
- Cancer, Lipids, and Metabolism 4
Biochemistry top 5%
Molecular Biology
- Peroxisome Proliferator-Activated Receptors 8
Computational Theory and Mathematics
- Computational Drug Discovery Methods 6
Immunology
- Atherosclerosis and Cardiovascular Diseases 5
Cardiology and Cardiovascular Medicine
- Lipid metabolism and disorders 5

Co-authors: Brian R. Krause John S. Parks Roger S. Newton Joseph A. Cornicelli Charles L. Bisgaier John S. Kiely Deborah Applebaum‐Bowden Kylie Kavanagh
Cited by: Endocrinology, Diabetes and Metabolism Surgery Biochemistry
Journals: Atherosclerosis (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Lipid Research (5 papers)
Partner nations: United States Russia Canada

In The Last Decade

Bruce J. Auerbach

39 papers receiving 1.3k citations

Peers

Countries citing papers authored by Bruce J. Auerbach

Since Specialization

Citations

This map shows the geographic impact of Bruce J. Auerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce J. Auerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce J. Auerbach more than expected).

Fields of papers citing papers by Bruce J. Auerbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce J. Auerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce J. Auerbach. The network helps show where Bruce J. Auerbach may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bruce J. Auerbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce J. Auerbach Line = papers co-authored together Bruce J. Auerbach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prevention of bleomycin‐induced lung fibrosis via inhibition of the MRTF/SRF transcription pathway Pharmacology Research & Perspectives ·Kendell M. Pawelec,Megan Varnum,Jack R. Harkema,Bruce J. Auerbach,Scott D. Larsen,Richard R. Neubig	2022	13
2	Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement Journal of clinical lipidology ·Robert D. Shamburek,Rebecca Bakker‐Arkema,Bruce J. Auerbach,Brian R. Krause,Reynold Homan,Marcelo Amar,Lita A. Freeman,Alan T. Remaley	2015	73
3	Effect of Recombinant Human Lecithin Cholesterol Acyltransferase Infusion on Lipoprotein Metabolism in Mice Journal of Pharmacology and Experimental Therapeutics ·Xavier Rousset,Boris Vaisman,Bruce J. Auerbach,Brian R. Krause,J. L.,John A. Stonik,György Csákó,Robert D. Shamburek,Alan T. Remaley	2010	59
4	A Selective Peroxisome Proliferator-Activated Receptor α Agonist, CP-900691, Improves Plasma Lipids, Lipoproteins, and Glycemic Control in Diabetic Monkeys Journal of Pharmacology and Experimental Therapeutics ·Janice D. Wagner,Melanie K. Shadoan,Li Zhang,A. C. P. ORO,Lori Royer,Kylie Kavanagh,Omar L. Francone,Bruce J. Auerbach,H. James Harwood	2010	25
5	A Selective Cannabinoid-1 Receptor Antagonist, PF-95453, Reduces Body Weight and Body Fat to a Greater Extent than Pair-Fed Controls in Obese Monkeys Journal of Pharmacology and Experimental Therapeutics ·Janice D. Wagner,Li Zhang,Kylie Kavanagh,A. C. P. ORO,Janice E. Chin,John R. Hadcock,Bruce J. Auerbach,H. James Harwood	2010	20
6	Synthesis and evaluation of novel α-heteroaryl-phenylpropanoic acid derivatives as PPARα/γ dual agonists Bioorganic & Medicinal Chemistry ·Agustin Casimiro‐Garcia,Christopher F. Bigge,Jo Ann Davis,Amanda dos Santos Gonçalves,Duncan Galley,Jeffrey F. Ohren,Patrick McConnell,Christopher D. Kane,Lori Royer,Kimberly A. Stevens,Bruce J. Auerbach,Wendy T. Collard,J. T. Assis,Kun Song	2009	16
7	Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors Bioorganic & Medicinal Chemistry Letters ·William K.C. Park,Robert M. Kennedy,Scott D. Larsen,Steve Miller,Bruce D. Roth,Yuntao Song,Bruce A. Steinbaugh,Pasiskevicius,Bradley D. Tait,Mark C. Kowala,Bharat K. Trivedi,Bruce J. Auerbach,FU Yao-yao,Birte Wiebusch,Jeffrey C. Hanselman,Zhiwu Lin,Gina H. Lu,Andrew Robertson,Catherine Sekerke	2007	45
8	Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Pfefferkorn,Chulho Choi,Yuntao Song,Bharat K. Trivedi,Scott D. Larsen,FU Yao-yao,Birte Wiebusch,Jeffrey C. Hanselman,Zhiwu Lin,Gina H. Lu,Andrew Robertson,Catherine Sekerke,Bruce J. Auerbach,A.G. Pavlovsky,Melissa S. Harris,Graeme Bainbridge,Nicole Caspers	2007	30
9	Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design Bioorganic & Medicinal Chemistry Letters ·Scott D. Larsen,Policarpio B. Joves,Kevin J. Filipski,Jeffrey T. Kohrt,Jeffrey A. Pfefferkorn,Roderick J. Sorenson,Bradley D. Tait,FU Yao-yao,Birte Wiebusch,Jeffrey C. Hanselman,Gina H. Lu,Andrew Robertson,Catherine Sekerke,Mark C. Kowala,Bruce J. Auerbach	2007	11
10	Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Pfefferkorn,Scott D. Larsen,J. Grebert,Roderick J. Sorenson,谢迪扬,G Galatà,Bruce J. Auerbach,Chenyan Wu,Florian Relis,Marília Ortiz Amando de Barros,Kathleen M. Welch,Naren Emmanuel Carpio Silva et al.,SELİM CENGİZ,Richard F. Bousley,Karl Olsen,Sandra Bak Mueller,Thomas Mertz	2007	18
11	Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase Bioorganic & Medicinal Chemistry ·啓明川島,Bruce J. Auerbach,Chulho Choi,Birte Wiebusch,Jeffrey C. Hanselman,Scott D. Larsen,Gina H. Lu,Karl Olsen,Jeffrey A. Pfefferkorn,Andrew Robertson,Catherine Sekerke,Bharat K. Trivedi,Paul C. Unangst	2007	25
12	Old World Nonhuman Primate Models of Type 2 Diabetes Mellitus ILAR Journal ·Janice D. Wagner,Kylie Kavanagh,여해경,Bruce J. Auerbach,H. James Harwood,Jay R. Kaplan	2006	135
13	Influence of lipoprotein(a) plasma concentration on neointimal growth in a monkey model of vascular injury Atherosclerosis ·Michael J. Ryan,Arsenio Sánchez Argüeso. Graduado en Medicina Arsenio Sánchez Argüeso. Graduado en Medicina,Annie Devalckenaere,Marit Løset Eriksen,David W. Brammer,David Gordon,Bruce J. Auerbach,Joan A. Keiser	1998	2
14	Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors Journal of Lipid Research ·C L Bisgaier,Arnold D. Essenburg,Bruce J. Auerbach,M E Pape,Catherine Sekerke,Andrew Gee,Paulo de Tarso Rocha Mendonça,Roger S. Newton	1997	66
15	Oxidation of Low Density Lipoproteins Greatly Enhances Their Association with Lipoprotein Lipase Anchored to Endothelial Cell Matrix Journal of Biological Chemistry ·Bruce J. Auerbach,Charles L. Bisgaier,Joachim Wölle,Uday Saxena	1996	56
16	Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats Atherosclerosis ·Brian R. Krause,Yeteng Wang,Arnold D. Essenburg,Karen A. Kieft,Bruce J. Auerbach,Richard F. Bousley,Richard L. Stanfield,Roger S. Newton,C L Bisgaier	1996	18
17	Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: Atorvastatin versus lovastatin Atherosclerosis ·Bruce J. Auerbach,Brian R. Krause,Charles L. Bisgaier,Roger S. Newton	1995	44
18	Lipoprotein Lipase Facilitates Very Low Density Lipoprotein Binding to the Subendothelial Cell Matrix Biochemical and Biophysical Research Communications ·Uday Saxena,Erika Ferguson,Bruce J. Auerbach,C L Bisgaier	1993	17
19	A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women Metabolism ·Perry L. Colvin,Bruce J. Auerbach,L. Douglas Case,William R. Hazzard,Deborah Applebaum‐Bowden	1991	56
20	Differential Effects of Oral Estrone Versus 170-Estradiol on Lipoproteins in Postmenopausal Women* The Journal of Clinical Endocrinology & Metabolism ·Perry L. Colvin,Bruce J. Auerbach,Donald R. Koritnik,William R. Hazzard,Deborah Applebaum‐Bowden	1990	21

About Bruce J. Auerbach

Bruce J. Auerbach is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Biochemistry, Computational Theory and Mathematics and Cancer Research, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (20 papers), Cholesterol and Lipid Metabolism (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Computational Drug Discovery Methods (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Lipid metabolism and disorders (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (407 citations), Surgery (605 citations), Biochemistry (79 citations), Cancer Research (186 citations) and Biochemistry (86 citations). Bruce J. Auerbach has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Brian R. Krause, John S. Parks, Roger S. Newton, Joseph A. Cornicelli, Charles L. Bisgaier, John S. Kiely, Deborah Applebaum‐Bowden, Kylie Kavanagh, Janice D. Wagner and H. James Harwood. Their work appears in journals such as Atherosclerosis, Bioorganic & Medicinal Chemistry Letters, Journal of Lipid Research, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact